Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Thailand grants first approval for WF-10

Sep. 17, 1997

Meiji Milk introduces new hepatitis B vaccine

Sep. 17, 1997

Promising preliminary phase III results reported for Lyme disease vaccine

Sep. 16, 1997

MGH and BioTransplant report advances in xenotransplantation research

Sep. 16, 1997

In vitro and in vivo antibacterial activity of two herbal medicines

Sep. 12, 1997

BioFocus and RDW begin collaboration for T-cell enzyme inhibitors

Sep. 10, 1997

New orally active immunosuppressant for combination with ciclosporin

Sep. 9, 1997

Roche seeks European approval for humanized monoclonal antibody

Sep. 5, 1997

Russian scientists report on myelopeptides

Sep. 5, 1997

UDCA suppresses allograft rejection after heart transplant

Sep. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...